According to the agreement, Summit Products Group will distribute Hydrelix, NovaForm, and G4Derm Plus, designed to complement MiMedx’s portfolio of leading surgical and wound products.
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
MIMEDX Group (MDXG) reports record Q2 2025 earnings, beating revenue and EPS estimates with $98.61M in sales and $0.10 EPS. Stock surges 11.8% post-announcement.
